---
title: "INCY.US (INCY.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/INCY.US/news.md"
symbol: "INCY.US"
name: "INCY.US"
parent: "https://longbridge.com/en/quote/INCY.US.md"
datetime: "2026-05-20T14:47:41.962Z"
locales:
  - [en](https://longbridge.com/en/quote/INCY.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/INCY.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/INCY.US/news.md)
---

# INCY.US (INCY.US) — Related News

### [Incyte expands Genesis Molecular AI collaboration, pays USD 120 million upfront](https://longbridge.com/en/news/287060301.md)
*2026-05-20T12:01:26.000Z*
> Incyte has expanded its collaboration with Genesis Molecular AI, paying USD 120 million upfront, which includes USD 80 m

### [Incyte Stock: Analyst Estimates & Ratings](https://longbridge.com/en/news/286932283.md)
*2026-05-19T14:38:22.000Z*
> Incyte Stock: Analyst Estimates & Ratings

### [Incyte CEO Says Post-Jakafi Growth Path Is Clearer as Pipeline Catalysts Build](https://longbridge.com/en/news/286716316.md)
*2026-05-18T05:10:43.000Z*
> Incyte CEO Bill Meury highlighted the company's clearer post-Jakafi growth path, driven by ongoing commercial growth and

### [Incyte Corp. Stock Underperforms Friday When Compared To Competitors](https://longbridge.com/en/news/286616241.md)
*2026-05-15T21:06:43.000Z*
> Incyte Corp. (INCY) shares fell 2.38% to $95.31 on Friday, marking the fourth consecutive day of losses. The stock is 15

### [Incyte Corp. Stock Underperforms Thursday When Compared To Competitors](https://longbridge.com/en/news/286469104.md)
*2026-05-14T21:07:07.000Z*
> Incyte Corp. (INCY) shares fell 1.20% to $97.63 on Thursday, marking the third consecutive day of losses, despite a posi

### [Incyte Corp. Stock Underperforms Tuesday When Compared To Competitors](https://longbridge.com/en/news/286158548.md)
*2026-05-12T21:07:35.000Z*
> Incyte Corp. (INCY) shares fell 1.19% to $99.13 on Tuesday, ending a two-day winning streak, while the Dow Jones rose 0.

### [Prelude Therapeutics Inc 1Q 2026: Revenue $4.58M, EPS $(0.13) — 10-Q Summary](https://longbridge.com/en/news/286088885.md)
*2026-05-12T11:21:00.000Z*
> Prelude Therapeutics Inc reported Q1 2026 revenue of $4.58M, a significant increase from $0.0 in Q1 2025, driven by an u

### [Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association (EHA) 2026 Congress | INCY Stock News](https://longbridge.com/en/news/286109604.md)
*2026-05-12T05:30:46.000Z*
> Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association (EHA) 2026 Cong

### [Incyte Corp. Stock Outperforms Competitors On Strong Trading Day](https://longbridge.com/en/news/285998147.md)
*2026-05-11T21:08:43.000Z*
> Incyte Corp. (INCY) shares rose 1.79% to $100.32 on a strong trading day, outperforming competitors like Alnylam Pharmac